Avendus, SBI Life pick up over 2.5% secondaries in Aragen for Rs 300 crore

Avendus Future Leaders Fund III and SBI Life Insurance have jointly invested Rs 300 crore in Aragen Life Sciences, a Hyderabad-based CRDMO. The investment involves acquiring a stake from the GVK Group's Reddy family. This move allows investors to capitalize on the increasing trend of global pharmaceutical companies outsourcing R&D and manufacturing to India.